Literature DB >> 8669528

Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations.

J E McNeal1, C E Yemoto.   

Abstract

Malignant epithelial masses within prostatic duct lumens have been equated with several conflicting entities, including Gleason cribriform grade 3 carcinoma and cribriforming dysplasia. We identified 51 radical prostatectomy cancers containing intraductal lesions among 130 cases, with total cancer volumes between 4 and 10 cc. Such lesions with duct lumen-spanning septa or masses were rare in areas away from invasive cancer (22 foci), while dysplasia (prostatic intraepithelial neoplasia) was common (1,490 foci). Consequently, these lesions were interpreted as being part of the evolution of invasive carcinoma rather than precursors; they were designated "intraductal carcinoma" as distinct from dysplasia. Intraductal cancer areas within invasive carcinoma usually represented cancer extension within the branches of a single segment of the duct-acinar system from near the urethra to the gland capsule. In 51% of cases with intraductal spread, the invasive component produced large ( > 0.5 mm) tumor masses in perineural spaces, which in turn correlated strongly with extensive capsule penetration and frequent positive surgical margins selectively at the superior nerve pedicle. The amount of grade 4/5 cancer, the amount of intraductal carcinoma, and the large perineural tumor mass appeared to be related to postprostatectomy progression of cancer, as measured by elevation of ultrasensitive serum prostate-specific antigen. It was concluded that intraductal prostatic adenocarcinoma is a common morphologic entity with precisely defined histologic criteria and a unique biologic significance, as reflected by an enhanced capacity for extensive spread within ducts and perineural spaces. It was proposed that the diversity of diagnoses attached to most cribriform malignant lesions can be unified by the concept of this single entity.

Entities:  

Mesh:

Year:  1996        PMID: 8669528     DOI: 10.1097/00000478-199607000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  41 in total

1.  [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Authors:  G Kristiansen; L Egevad; M Amin; B Delahunt; J R Srigley; P A Humphrey; J I Epstein
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

2.  Seminal vesicle invasion by prostate cancer: prognostic significance and therapeutic implications.

Authors:  S R Potter; J I Epstein; A W Partin
Journal:  Rev Urol       Date:  2000

Review 3.  Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.

Authors:  Jeffrey J Tosoian; Stacy Loeb; Jonathan I Epstein; Baris Turkbey; Peter L Choyke; Edward M Schaeffer
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

4.  Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.

Authors:  Kosuke Miyai; Mukul K Divatia; Steven S Shen; Brian J Miles; Alberto G Ayala; Jae Y Ro
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 5.  Intraductal carcinoma of prostate (IDC-P): from obscure to significant.

Authors:  Ni Chen; Qiao Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

6.  Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.

Authors:  Ekaterina Olkhov-Mitsel; Farshid Siadat; Ken Kron; Liyang Liu; Andrea J Savio; John Trachtenberg; Neil Fleshner; Theodorus van der Kwast; Bharati Bapat
Journal:  Oncol Lett       Date:  2017-05-09       Impact factor: 2.967

7.  Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate.

Authors:  Akiyuki Yamamoto; Masashi Kato; Hirotaka Matsui; Ryo Ishida; Tohru Kimura; Yasuhito Funahashi; Naoto Sassa; Yoshihisa Matsukawa; Osamu Kamihira; Ryohei Hattori; Momokazu Gotoh; Toyonori Tsuzuki
Journal:  Int J Clin Oncol       Date:  2018-02-03       Impact factor: 3.402

Review 8.  Precursor lesions to prostatic adenocarcinoma.

Authors:  Jonathan I Epstein
Journal:  Virchows Arch       Date:  2008-12-02       Impact factor: 4.064

9.  The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation.

Authors:  Masashi Kato; Toyonori Tsuzuki; Kyosuke Kimura; Akihiro Hirakawa; Fumie Kinoshita; Naoto Sassa; Ryo Ishida; Akitoshi Fukatsu; Tohru Kimura; Yasuhito Funahashi; Yoshihisa Matsukawa; Ryohei Hattori; Momokazu Gotoh
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

10.  Original and infiltrating patterns of prostatic carcinoma.

Authors:  Nobuki Furubayashi; Motonobu Nakamura; Keniti Nishiyama; Yoshihiro Hasegawa
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.